NOV 10, 2016 11:23 AM PST

High-Intensity Statins Help Heart Disease Patients Live Longer

WRITTEN BY: Kara Marker
High-intensity statin treatments increase the chance of survival for individuals with cardiovascular disease, as compared to moderate-intensity statins.
Source: Medical News Today
"Previously, there was definitely a certain amount of fear on the patient's part because most people don't like taking medication," said senior author Paul Heidenreich, MD. Statins are a class of drugs that prevent the progression of cardiovascular disease by lowering cholesterol levels in the blood, preventing atherosclerotic plaque buildup that hinders healthy blood flow. Although they indirectly prevent heart attack and stroke, there are also some studies showing side effects like diabetes and muscle damage associated especially with higher-intensity statin treatments.

Conducted for a full 365 days, the Stanford University Medical Center study’s results support American College of Cardiology and American Heart Association recommendations for high-intensity statins for patients with atherosclerotic cardiovascular disease under the age of 75, a statement that contradicted the more conservative guidelines put forth in 2014 by the Veterans Affairs Health Care System. This group cited studies showing the “lack of conclusive evidence” that a boost in drug intensity made a difference for heart disease patients.

However, by analyzing medical records from over 500,000 patients across the nation, Heidenreich’s results provided clear evidence that high-intensity statins increased rates of survival for both young, middle-aged, and elderly patients with heart disease. On average, patients taking the high-intensity statins showed a nine percent increased chance of survival compared to patients receiving moderate-intensity treatments.

"The greatest strength of this study is that we used a very large, well-defined clinical cohort," said lead author Fatima Rodriguez, MD. "The results show that high-intensity statins confer a survival advantage for patients with cardiovascular disease, including older adults." Rodriguez and the research team also had access to detailed clinical information, like comorbidities and cholesterol levels.

Researchers studied cardiovascular disease patients taking many different kinds of statins at different levels of intensity, as well as patients taking no statins at all. Each patient in the study was assigned a score that defined and described their need for high-intensity statins based on the severity of their disease.

With the benefits of using high-intensity statins clearly stated and published for the world to see, Rodriguez and the researchers from Stanford next plan on improving the system responsible for deciding which patients are best-suited for receiving high-intensity statins. "There are a lot of guidelines and recommendations out there, so I think we also have to make the system better," Rodriguez said. "Maybe hospitals can employ a clinical reminder to doctors, a message that pops up on the doctor's screen that asks why a cardiovascular patient isn't on a high-intensity statin."

Heidenreich said, "We think this should give clinicians, physicians and nurse practitioners more comfort in following the American College of Cardiology and American Heart Association guidelines and putting people with prior cardiovascular disease on a high-intensity statin."

The Stanford study was recently published in JAMA Cardiology.
 


Source: Stanford University Medical Center
About the Author
  • I am a scientific journalist and enthusiast, especially in the realm of biomedicine. I am passionate about conveying the truth in scientific phenomena and subsequently improving health and public awareness. Sometimes scientific research needs a translator to effectively communicate the scientific jargon present in significant findings. I plan to be that translating communicator, and I hope to decrease the spread of misrepresented scientific phenomena! Check out my science blog: ScienceKara.com.
You May Also Like
MAR 20, 2020
Drug Discovery & Development
WHO Says Ibuprofen May Still Work Against COVID-19
MAR 20, 2020
WHO Says Ibuprofen May Still Work Against COVID-19
Since the announcement of a French Health Minister in recent days linking usage of ibuprofen and other non-steroidal ant ...
MAR 20, 2020
Cardiology
Exercise For Persons With COPD
MAR 20, 2020
Exercise For Persons With COPD
The thought of starting an exercise program can be daunting, particularly for those who have been diagnosed with chronic ...
MAR 25, 2020
Cardiology
Staying Fit While Avoiding COVID-19
MAR 25, 2020
Staying Fit While Avoiding COVID-19
For those used to working out at a gym, the current circumstances requiring us all to remain isolated as much as possibl ...
APR 03, 2020
Cardiology
How Cardiovascular Disease Increases Mortality Risk of COVID-19
APR 03, 2020
How Cardiovascular Disease Increases Mortality Risk of COVID-19
Although initial reports focused mostly on COVID 19’s respiratory effects, including pneumonia and difficulty brea ...
APR 07, 2020
Immunology
Too Much Salt Is Bad for the Immune System
APR 07, 2020
Too Much Salt Is Bad for the Immune System
Excessive salt intake is associated with health consequences for more than just cardiovascular status; the immune system ...
JUL 04, 2020
Cardiology
Discovering a New Signal Junction Controlling Pulmonary Arterial Hypertension
JUL 04, 2020
Discovering a New Signal Junction Controlling Pulmonary Arterial Hypertension
Pulmonary Arterial Hypertension (PAH) is a progressive and fatal disease characterized by the muscularization of blood c ...
Loading Comments...